| Entry |
|
|---|
| Name |
Nelipepimut-S (USAN);
Neuvax |
|---|
| Formula |
C50H78N10O11
|
|---|
| Exact mass |
994.5852
|
|---|
| Mol weight |
995.21
|
|---|
| Class |
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG03158 HER2 inhibitor
|
|---|
| Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
|---|
| Comment |
Cancer immunotherapy for prevention and delay of cancer recurrence
|
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01918 Tyrosine kinase inhibitor
DG01917 Receptor tyrosine kinase inhibitor
DG03158 HER2 inhibitor
D10344 Nelipepimut-S
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
EGFR family
ERBB2 (HER2, CD340)
D10344 Nelipepimut-S (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
